Ebola and Marburg Infections-Pipeline Insights, 2014

Bharat Book Bureau presents the new report, on "Ebola and Marburg Infections-Pipeline Insights, 2014". The report also covers the companies information involved in the therapeutic development of the products. It also has highlighted the discontinued and dormant products.

SUMMARY

'Ebola and Marburg Infections-Pipeline Insights, 2014', report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Ebola and Marburg Infections. This report provides information on the therapeutic development based on the Ebola and Marburg Infections dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, IND filed, Preclinical, Discovery and unknown stages, therapeutics assessment by monotherapy and combination products and molecule type drug information. The report also covers the companies information involved in the therapeutic development of the products. It also has highlighted the discontinued and dormant products.

Scope

• The report provides a snapshot of the global therapeutic landscape of Ebola and Marburg Infections
• The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
• Coverage of the Ebola and Marburg Infections pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
• The report reviews key players involved in the therapeutics development for Ebola and Marburg Infections and also provide company profiling
• The report also gives the information of dormant and discontinued pipeline projects
• Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
• Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type

Reasons to buy

• Complete Pipeline intelligence and complete understanding over therapeutics development for Ebola and Marburg Infections
• Identify the relationship between the drugs and use it for target finding, drug repurposing, and precision medicine.
• Devise corrective measures for pipeline projects by understanding Ebola and Marburg Infections pipeline depth and focus of Indication therapeutics
• Developing strategic initiatives to support your drug development activities.
• Optimize your portfolio and keep you in touch with the rapidly changing pharmaceutical markets, and make the best decisions for your business.
• Develop and design in licensing and out licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
• Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
• Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
• Gaining a Full Picture of the Competitive Landscape for Evidence based Decisions

Table of  Contents

• Ebola and Marburg Infections Overview
• Ebola and Marburg Infections Pipeline Therapeutics
• Ebola and Marburg Infections Therapeutics under Development by Companies
• Ebola and Marburg Infections Late Stage Products (Filed and Phase III)
• Ebola and Marburg Infections Mid Clinical Stage Products (Phase II)
• Ebola and Marburg Infections Early Clinical Stage Products (Phase I and IND Filed)
• Ebola and Marburg Infections Discovery and Pre-Clinical Stage Products
• Ebola and Marburg Infections – Therapeutics Assessment
• Ebola and Marburg Infections – Discontinued Products
• Ebola and Marburg Infections – Dormant Products

List of Tables

• Number of Products under Development for Ebola and Marburg Infections, 2014
• Number of Products under Development by Companies
• Comparative Analysis by Late Clinical Stage Products (Filed and Phase III), 2014
• Comparative Analysis Mid Clinical Stage Products (Phase II), 2014
• Comparative Analysis Early Clinical Stage Products (Phase I and IND Filed), 2014
             
About Bharat Book Bureau:

Bharat Book Bureau is the leading market research information provider for market research reports, company profiles, industry analysis , country reports , business reports, newsletters and online databases Bharat Book Bureau provides over a million reports from more than 400 publishers around the globe. We cover sectors starting from Aeronautics to Zoology.

In case the reports don’t match your requirement then we can do a specialized Custom Research for you. Our multifarious capabilities, cross-sector expertise and detailed knowledge of various markets, put us in a unique position to take up Custom Research demands of yourself.

 ###